Filter Results :

Your search for Diseases returned 196 reports

Sort by


The Top 250 Developers of In-Vitro Diagnostics Tests for Cancer, Cardiovascular & Infectious Diseases

10 Mar 2017  |  Published by:  Research Facts
Did you know?- Daniella Cramp is Global President, Cardiometabolic at Alere Inc..- Beijing Wantai Biological Pharmacy’s Beijing plant is the largest manufacturing base for the production of infectious diseases diagnostics in China.- MDxHealth was the winner of the 2016 Frost & Sullivan Global Pr...

$ 2,250.00

Read More

The Top 200 Developers of In-Vitro Diagnostics Tests for Cancer & Infectious Diseases

02 Mar 2017  |  Published by:  Research Facts
Did you know?- Lewis Stuart is Vice President, Sales & Marketing, U.S. Breast/Colon at Genomic Health, Inc.. - Beijing Wantai Biological Pharmacy’s Beijing plant is the largest manufacturing base for the production of infectious diseases diagnostics in China.- MDxHealth was the winner of the 201...

$ 1,794.00

Read More

The Top 100 Developers of In-Vitro Diagnostics Tests for Infectious Diseases

23 Feb 2017  |  Published by:  Research Facts
Did you know?Avi Pelossof is Global President, Infectious Disease at Alere, Inc.. Beijing Wantai Biological Pharmacy's Beijing plant is the largest manufacturing base for the production of infectious diseases diagnostics in China. Diagnostic Bioprobes s.r.l has over 30 years of international experie...

$ 1,109.00

Read More

Global Lysosomal Storage Diseases Market Research Report 2017

06 Feb 2017  |  Published by:  9Dimen Research
Lysosomal Storage Diseases Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United Sta...

$ 2,850.00
$ 2,565.00
( Save 10% )

Read More

Global Sexually Transmitted Diseases Partnering 2010-2017

01 Feb 2017  |  Published by:  CurrentPartnering
Provides understanding and access to the sexually transmitted diseases partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Sexually Transmitted Diseases Partnering Terms and Agreements since 2010 report provides understanding and access to partne...

$ 1,495.00

Read More

Global Orphan Diseases Partnering 2010-2017: Deal trends, players and financials

01 Feb 2017  |  Published by:  CurrentPartnering
The Global Orphan Diseases Partnering 2010-2017: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the orphan diseases partnering deals and agreements entered into by the worlds leading healthcare companies.Global Orphan Diseases Partnering 2...

$ 2,995.00

Read More

Global Infectious Diseases Partnering 2010-2017: Deal trends, players and financials

01 Feb 2017  |  Published by:  CurrentPartnering
Global Infectious Diseases Partnering 2010-2017: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies.Global Infectious Diseases Partnering 20...

$ 3,495.00

Read More

Global Musculoskeletal System Diseases Market Research Report 2017

29 Jan 2017  |  Published by:  9Dimen Research
Musculoskeletal System Diseases Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (Unite...

$ 2,850.00
$ 2,565.00
( Save 10% )

Read More

Global Musculoskeletal Diseases Market Research Report 2017

29 Jan 2017  |  Published by:  9Dimen Research
Musculoskeletal Diseases Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United State...

$ 2,850.00
$ 2,565.00
( Save 10% )

Read More

Humanized Mouse Model Market by Type (Genetic, Cell-based (CD34, PBMC, BLT)), Application (Neuroscience, Hematopoiesis, Oncology, Immunology & Infectious diseases) & End User(Pharmaceutical & Biotech Companies, CRO)) - Global Forecast to 2021

23 Jan 2017  |  Published by:  MarketsandMarkets
The humanized mouse model market is projected to reach USD 116.0 million by 2021 from USD 73.3 million in 2016, growing at a CAGR of 9.6% in the next five years (2016 to 2021). Growing adoption of personalized medicine to fuel the demand for personalized mice models, continuous support in the form o...

$ 5,650.00

Read More

Immunotherapy Drugs Market by Type of Drugs (Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha), Therapy Area (Cancer, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals), Region (North America, Asia-Pacific) - Global Forecast to 2021

06 Jan 2017  |  Published by:  MarketsandMarkets
The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.  In this report, the immunotherapy drugs market is segmented on the basis of type of drugs, therapy area...

$ 5,650.00

Read More

Inflammatory Skin Diseases-Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Inflammatory Skin Diseases-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Inflammatory Skin Diseases. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, ...

$ 1,250.00

Read More

Motor Neurone Diseases-Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Motor Neurone Diseases-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Motor Neurone Diseases. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Pha...

$ 1,250.00

Read More

Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Graves Diseases Report is to understand the mark...

$ 2,000.00

Read More

Graves Diseases - Pipeline Review, H2 2016

30 Dec 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Pipeline Review, H2 2016, provides an overview of the Graves Diseases (Hormonal Disorders) pipeline landscape.Graves' disease is an immune system disorder that results in the overproduction of ...

$ 2,000.00

Read More
Total 196 records.